Skip to main content
Clinical Trials/JPRN-jRCT1030220303
JPRN-jRCT1030220303
Recruiting
N/A

Cross-sectional analysis of psychiatric disorders based on AMPA receptor density

Miyazaki Tomoyuki0 sites219 target enrollmentAugust 31, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Miyazaki Tomoyuki
Enrollment
219
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 31, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Miyazaki Tomoyuki

Eligibility Criteria

Inclusion Criteria

  • The data must be from a pilot study (UMIN000025132\) to compare the efficacy of the radioligand \[11C]K\-2 in the development of cross\-disease diagnostics in depression, bipolar disorder, schizophrenia, addiction, ASD, epilepsy, FTD cases and healthy controls, and \[11C]K\-2 imaging data and MRI imaging data stored in the Department of Physiology, Yokohama City University, which can be analyzed in patients with depression, bipolar disorder, schizophrenia and ASD and in healthy controls.
  • The data were obtained in the 'A clinical trial to examine age\-and\-sex\-related changes of AMPA receptor density in healthy volunteers.' and the data should be analyzable in males in their 20s\-40s.
  • The data should be from \[11C]K\-2 images and MRI images taken in a cross\-sectional PET study using \[11C]K\-2 (jRCTs031190197\) and stored in the Department of Physiology, Yokohama City University, and should be available for analysis.
  • The data must be from \[11C]K\-2 imaging data and MRI imaging data taken in a cross\-sectional PET study using \[11C]K\-2 (jRCTs031190150\) and stored in the Department of Physiology, Yokohama City University, and must be available for analysis.
  • The data must be from \[11C]K\-2 imaging data and MRI imaging data taken in a cross\-sectional PET study using \[11C]K\-2 (jRCTs031190149\) and stored in the Department of Physiology, Yokohama City University, and must be available for analysis.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials